Showing 2491-2500 of 20412 results for "".
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
https://reachmd.com/programs/project-oncology/coordinating-care-for-mcspc-patients-receiving-androgen-receptor-pathway-inhibitors/49231/Managing metastatic castration-sensitive prostate cancer (mCSPC) with androgen receptor pathway inhibitors (ARPIs) means thinking beyond the initial response and helping patients stay on treatment long term while maintaining quality of life. Ongoing attention to side effects, cardiovascular and cognNavigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
https://reachmd.com/programs/project-oncology/akt-inhibitor-ae-hr-positive-her2-negative-bc/54762/AKT inhibition offers a targeted approach to overcoming endocrine resistance in HR+/HER2- advanced breast cancer. However, treatment is associated with adverse events like hyperglycemia, rash, and diarrhea. In this conversation with Dr. Alexandria May, Dr. Adam Brufsky outlines how to assess baselinILDS Joins the Lancet Commission on Skin Health
https://reachmd.com/videos/skin-minute/ilds-joins-the-lancet-commission-on-skin-health/57085/Esther Freeman, MD, talks about the International League of Dermatologic Society (ILDS) and its new contributions to The Lancet’s new Commission focusing exclusively on skin health. It’s the first time the publication has devoted one of its highly regarded Commissions on skin health.Controlling the Itch in Prurigo Nodularis
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/controlling-the-itch-in-prurigo-nodularis/37169/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, discusses what he says is the biggest unmet need in prurigo nodularis patient care.Enhancing IgAN Care: The Importance of a Proactive Approach
https://reachmd.com/programs/clinicians-roundtable/enhancing-igan-care-the-importance-of-a-proactive-approach/37213/Although IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world, it’s easy to miss and can lead to irreversible kidney damage, underscoring the importance of proactively identifying, monitoring, and treating patients. That’s why Dr. Gates Colbert speaks with Dr. Suneel UdaEpigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
https://reachmd.com/programs/neurofrontiers/epigenetic-immune-signatures-in-alzheimers-implications-for-diagnosis-and-therapy/36464/Patients with Alzheimer's disease—especially APOE4 carriers—show distinct epigenetic immune alterations that may influence disease progression, treatment response, and side effect risk. In this episode, Dr. David Gate, an Assistant Professor of Behavioral Neurology at Northwestern University, divesModerna’s 2024–2025 COVID-19 Vaccine: Composition Updates and Interim Effectiveness Data
https://reachmd.com/programs/clinicians-roundtable/modernas-20242025-covid-19-vaccine-composition-updates-and-interim-effectiveness-data/35462/Through its antigenic and operational updates, the 2024–2025 SPIKEVAX® COVID-19 vaccine has demonstrated moderate protection against current variants. Learn about the vaccine’s new composition as well as its interim effectiveness data with this in-depth review.Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
https://reachmd.com/programs/neurofrontiers/inflammatory-gateways-exploring-the-role-of-the-choroid-plexus-in-post-tbi-care/32868/Traumatic brain injuries (TBIs) trigger a rapid transcriptional response in the choroid plexus, dominated by chemokines that attract neutrophils. Join Dr. Prajwal Ciryam, Assistant Professor of Neurology at the University of Maryland School of Medicine, as he explains how this early signaling may reDelivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
https://reachmd.com/programs/project-oncology/delivering-guideline-based-hepatocellular-carcinoma-care-with-an-interactive-tool/26320/Learn about a tool that can help clinicians implement the latest guidelines when diagnosing and treating patients with hepatocellular carcinoma.Elderly Patients with IBD: Management Strategies and Care
https://reachmd.com/programs/gi-insights/elderly-patients-with-ibd-management-strategies-and-care/18101/What are some challenges that arise when diagnosing elderly patients with IBD? Find out here.